2022 FIT Symposium: Networking and the Job Search

Save the Date! Cardiology Fellows-in-Training will have the opportunity to hear from some of Minnesota’s top cardiologists about their real-world experiences during the transition from training to practice. We will have a panel discussion for approximately 90 minutes, with time outside of that for questions and networking.

PANELISTS:

  • Catherine (Katie) Benziger, MD, MPH, FACC, FAHA – Essentia Health
  • Michelle Carlson, MD, FACC – Hennepin Healthcare
  • Selma Carlson, MD, FACC – Minneapolis VA & University of Minnesota Medical School
  • Jane Chen, MD, FACC, FHRS – University of Minnesota
  • Michael Cullen, MD, FACC – Mayo Clinic
  • Andrea Elliott, MD, FACC – University of Minnesota
  • William (Bill) Katsiyiannis, MD, FACC – Minneapolis Heart Institute
  • Sheetal (Sunny) Kaul, MD, MBBS, FACC – HealthPartners
  • Carmelo Panetta, MD, FACC – University of MN Physicians
  • Retu Saxena, MD, FACC – Minneapolis Heart Institute
  • Gautam R. Shroff, MBBS, FACC – Hennepin Healthcare
  • Mengistu A. Simegn, MD, FACC, FASE – Hennepin Healthcare
  • Stephen J. Smalley, MD, FACC – Essentia Health
  • Randall (Randy) Stark, MD, FACC – Metropolitan Heart & Vascular Institute
  • Sharath S. Subramanian, MBBS, MD, FACC – Centracare Heart & Vascular Center

CME Webinar: Anemia in Patients with CVD and CKD: Current Management and Potential Role of HIF-PHIs

Program Overview:

Anemia in CKD is associated with poor CV outcomes, increased risk of CKD progression, decreased health-related quality of life (HRQOL), and increased healthcare resource utilization. Erythropoiesis-stimulating agents have been the standard of care for treating anemia in CKD but are associated with CV safety concerns; other therapies include red blood cell transfusions and iron administration, but each potentially has severe adverse events.

Hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs) are promising novel agents in development for treating CKD-associated anemia. These oral agents increase endogenous erythropoietin production, improve iron absorption and mobilization, and decrease hepcidin production in the liver.

Anemia in Patients with CVD and CKD: Current Management and Potential Role of HIF-PHIs will provide cardiologists with information about the etiology of anemia in CKD, the effects on CV disease, HRQOL, and function, advantages and limitations of current management strategies, and the efficacy and safety data for HIF-PHIs in late-stage development for the management of CKD-related anemia.

Learning Objectives:

At the conclusion of this activity, participants should be able to:

  • Discuss the etiology of anemia in chronic kidney disease
  • Summarize how anemia affects functioning, quality of life, and health outcomes, for patients with cardiovascular disease and chronic kidney disease
  • Assess the benefits and limitations of available modalities for treating anemia in chronic kidney disease
  • Describe the mechanism of action of and efficacy and safety data for agents in late-stage development for the management of anemia of chronic kidney disease

Steering Committee:

Erin Michos, MD, MHS
Associate Professor of Medicine
Division of Cardiology
Johns Hopkins School of Medicine

Matthew Weir, MD
Professor and Chief
Division of Nephrology
Department of Medicine
University of Maryland School of Medicine

Jointly provided by USFH and Rockpointe.

This educational activity is supported by an educational grant from GlaxoSmithKline.

FIT Lecture Series: Mitral Valve Prolapse – When Does It Stop Being Benign? on Sept. 13

ACCMN FIT Lecture Series 09.13.22 Mitral Valve Prolapse and Mitral Annular Disjunction

Join us the second Tuesday of each month for our ongoing Fellows in Training (FIT) Lecture Series. On Tuesday, September 13th from 6-8 PM Iulia-Maria Tulai, M.D., Cardiology Fellow at the Minneapolis Heart Institute Foundation & Hennepin Healthcare, will present a talk on mitral valve prolapse.

This event is free, but registration is required. Register here and mark your calendars for the second Tuesday of every month to join us for future lectures.

Poster Contest Submissions Due Sept. 8

The 2022 Midwest Cardiovascular Forum will include a poster contest from 4:30-6:00pm on Saturday, October 29th at the Royal Sonesta Downtown Minneapolis.

  • There is Fellow, Resident, and a Medical Student tier in this contest.
  • There will be an award for first, second, and third place in each competition tier.
  • Regional representatives of the American College of Cardiology will judge all entries.
  • Submitting a Poster Abstract is free.
  • Conference Registration is free to those who have a poster accepted in the competition.
  • The deadline to submit your poster information is September 8th, 2022. The research or work submitted must be recent; June 2019-September 2022 should be the timeframe for consideration of poster work as we want to include good work that did not have an opportunity for in-person contests during the beginning of the pandemic.

Registration Opens for the 2022 Midwest Cardiovascular Forum

Attendees listen attentively to a speaker during the 2019 Midwest Cardiovascular Forum

After a two-year hiatus, the Midwest Cardiovascular Forum is returning this fall for a 1.5-day conference exploring the latest in cardiology! Sessions include topics for seasoned cardiologists, fellows-in-training, and cardiovascular team members. Join us in downtown Minneapolis from October 29-30.

Visit the Midwest Cardiovascular Forum web page for more details, and mark your calendar to attend.

NEW FIT Lecture Series: Pericarditis on Aug. 9

Join us the second Tuesday of each month for our ongoing Fellows in Training (FIT) Lecture Series. On Tuesday, August 9th from 6-8pm Kathryn F. Larson, M.D., Chief Fellow in the Division of Cardiology at Mayo Clinic will present a talk on Pericarditis.

This event is free, but registration is required. Register here and mark your calendars for the second Tuesday of every month to join us for future lectures.

Kathryn F. Larson, M.D.

Presentation

Using a case-based format, we will review the basics of diagnosis, ancillary testing, and therapeutics for pericarditis. The talk will include a discussion of the 2015 ESC Guidelines on pericardial disease, as well as a brief overview of key pivotal trials in the management of pericarditis (both initial episodes and recurrence).

Professional Development Series – Meet the Inventor: How TAVI Was Born

Saturday, May 14th, 2022

10 a.m. Central | Zoom

While listening to Julio Palmaz speak at a conference in Scottsdale, Arizona in February 1989, Henning Rud Andersen was inspired to concept implanting heart valves percutaneously. Within 3 months, Dr. Andersen made and implanted the first transcatheter heart valve in an animal model. Today, TAVI is the main treatment of severe aortic stenosis in many parts of the world. Join Drs. Mohamad Alkhouli and David R. Holmes for a virtual conversation with Dr. Andersen about his extraordinary journey with TAVI.

Moderators: Mohamad Alkhouli MD, FACC and David Holmes MD

Guest: Henning Rud Andersen MD

View the event flyer here.

2022 FIT Echo Bootcamp Registration Now Open

Presented by the Iowa and Minnesota Chapters of the American College of Cardiology

Registration is now open for our third annual FIT Echo Bootcamp. Join other Fellows in Training for an in-depth study on Echocardiographic Examinations and Emergencies led by Dr. Rick Marcus of the Iowa Heart Center. This four-part virtual series will take place from 6-8 pm Central on July 5th, 7th, 12th and 14th. Visit the FIT Echo Bootcamp page for more information.

Lifetime Management of Aortic Stenosis: Educational Opportunity in MN

In a growing number of sites across the country, structural heart programs are drawing on the experience of Advance Practice Providers to manage the continuum of care the Structural Heart patients. The MN APP Program has been designed to advance the care of patients with structural heart disease, with an emphasis on current challenging clinical topics coupled with the latest scientific evidence to guide patient treatment and long-term management of patients suffering from Aortic Stenosis. This program, presented by Edwards Lifesciences, is intended for Advanced Practice Providers (NPs, APNs, PA-Cs) in the greater MN area.

Topics for this program will include:

  • Timely Diagnosis and Treatment can lead to better outcome
  • Essential Role of various imaging modalities before, during and after TAVR
  • Evolution of APP leadership in Structural Heart Program
  • Strategies to streamline organizational process to build sustainable structural heart program (Pre, Peri, Post)
  • Importance of Multi-discipline Heart Team: Effective staffing models for clinic, procedure, and post-care

Date

Thursday, May 12, 2022
General Session: 1:00 PM – 7:00 PM CST

Location

Hotel Ivy – Grand Salon room
201 S 11th St.
Minneapolis, MN 55403

1 2